Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain

2018-10-12 10:43:18 | BioPortfolio


The goal of this study is to see if optimized use of naproxen for treatment of dysmenorrhea will improve pain report from baseline. In addition, we will determine whether cross-organ influences from the uterus on bladder pain sensitivity change from baseline after reduced menstrual pain experience over six months. Finally, a battery of quantitative sensory tests and EEG measures of sensory sensitivity will be used to evaluate mechanisms associated with improvements in menstrual and bladder pain.

Study Design






NorthShore University Health System
United States




NorthShore University HealthSystem Research Institute

Results (where available)

View Results


Published on BioPortfolio: 2018-10-12T10:43:18-0400

Clinical Trials [220 Associated Clinical Trials listed on BioPortfolio]

An Investigational Drug Study in the Treatment of Primary Dysmenorrhea

The purpose of this study is to evaluate the pain relieving effect and safety of an investigational drug in women with moderate to severe primary dysmenorrhea (painful menstruation).

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

The purpose of this study is to compare the maximum single dose of Aleve® (two tablets, equivalent to 440 mg of naproxen sodium) to the maximum single dose of Tylenol Extra Strength (two ...

The Effect of Turmeric on New Onset Primary Dysmenorrhea

The study was planned as 150 patients. Patients who met early-onset dysmenorrhea criteria and who met the inclusion criteria; 150 patients were divided into 2 equal groups, and NSAID durin...

Copper IUD Treatment Observation Study

Studies indicate that bleeding irregularities and dysmenorrhea are common reasons for copper IUD method discontinuation. Some evidence suggests that non-steroidal anti-inflammatory medicat...

Mechanistic Characterization of Uterine Pain

There are limited treatment options for management of dysmenorrhea, and the physiological processes they affect are not completely understood. For example, NSAIDs are effective in reducing...

PubMed Articles [52 Associated PubMed Articles listed on BioPortfolio]

Stroke risks in women with dysmenorrhea by age and stroke subtype.

Dysmenorrhea and stroke are health problems affecting women worldwide in their day-to-day lives; however, there is limited knowledge of the stroke risk in women with dysmenorrhea, and there have been ...

Therapeutic Exercise in the Treatment of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.

Dysmenorrhea is a health problem with a high impact on health and society. Some drugs have been shown to be effective at treating dysmenorrhea. Therapeutic exercise is another option for reducing the ...

Exploratory analysis of cold, heat, deficiency, or excess pattern distribution in women with dysmenorrhea.

To understand the impact and implications of cold, heat, deficiency, or excess pattern identification in relation to dysmenorrhea, comparing the prevalence of these patterns between women with and wit...

Viscero-visceral hyperalgesia in dysmenorrhea plus previous urinary calculosis: role of myofascial trigger points and their injection treatment in the referred area.

Women with dysmenorrhea plus symptomatic urinary calculosis experience enhanced pain and referred muscle hyperalgesia from both conditions than women with one condition only (viscero-visceral hyperalg...

Ionic liquid formation with deep eutectic forces at an atypical ratio (2:1) of naproxen to lidocaine in the solid-state, thermal characterization and FTIR investigation.

This study aimed to determine if an ionic liquid resulted from the combination of naproxen and lidocaine and the impact that varying the molar percentage of each component had on thermal behavior. Sam...

Medical and Biotech [MESH] Definitions

An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.

Painful menstruation.

A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.

More From BioPortfolio on "Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain"

Quick Search

Relevant Topic

Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Searches Linking to this Trial